Serum advanced glycation end products and matrix metalloproteinase-9 after renal transplantation

被引：0
|
作者：
Olga, M
Vladimir, T
Otto, S
Jiri, L
Stefan, V
Marta, K
Katerina, S
机构：
[1] Inst Clin Expt Med, Dept Nephrol Transplant Ctr, Prague, Czech Republic
[2] Charles Univ Prague, Sch Med 1, Prague, Czech Republic
[3] IPCM, Bratislava, Slovakia
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：V177 / V177
页数：1
相关论文
共 50 条
  • [41] Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis
    Röcken, C
    Kientsch-Engel, R
    Mansfeld, S
    Stix, B
    Stubenrauch, K
    Weigle, B
    Bühling, F
    Schwan, M
    Saeger, W
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04): : 1213 - 1220
  • [42] Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
    Iwamoto, Fabio M.
    Hottinger, Andreas F.
    Karimi, Sasan
    Riedel, Elyn
    Dantis, Jocelynn
    Jahdi, Maryam
    Panageas, Katherine S.
    Lassman, Andrew B.
    Abrey, Lauren E.
    Fleisher, Martin
    DeAngelis, Lisa M.
    Holland, Eric C.
    Hormigo, Adilia
    JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (03) : 607 - 612
  • [43] SERUM MATRIX METALLOPROTEINASE-9 LEVELS IN THE DIAGNOSIS OF FUNCTIONING ADRENAL TUMORS
    Berker, Dilek
    Isik, Serhat
    Erden, Gonul
    Tutuncu, Yasemin Ates
    Ozcan, Hatice Nursun
    Caner, Sedat
    Tekelek, Bekir
    Aydin, Yusuf
    Guler, Serdar
    ENDOCRINE PRACTICE, 2010, 16 (03) : 419 - 427
  • [44] Serum matrix metalloproteinase-9 levels in patients with acute myocardial infarction
    Guzel, Savas
    Serin, Ozden
    Yilmaz, Guzin
    Guzel, Eda Celik
    Guvenen, Guvenc
    CLINICAL BIOCHEMISTRY, 2009, 42 (4-5) : 342 - 342
  • [45] The role of serum matrix metalloproteinase-9 levels in the etiopathogenesis of nasal polyps
    Acar, Mustafa
    Gur, Ozer Erdem
    Kaymakci, Mustafa
    Ciftci, Onur
    Bugdayci, Guler
    Ozdem, Cafer
    ENT UPDATES, 2012, 2 (02): : 53 - 57
  • [46] Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke
    Zhong, Chongke
    Yang, Jingyuan
    Xu, Tan
    Xu, Tian
    Peng, Yanbo
    Wang, Aili
    Wang, Jinchao
    Peng, Hao
    Li, Qunwei
    Ju, Zhong
    Geng, Deqin
    Zhang, Yonghong
    He, Jiang
    NEUROLOGY, 2017, 89 (08) : 805 - 812
  • [47] Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
    Fabio M. Iwamoto
    Andreas F. Hottinger
    Sasan Karimi
    Elyn Riedel
    Jocelynn Dantis
    Maryam Jahdi
    Katherine S. Panageas
    Andrew B. Lassman
    Lauren E. Abrey
    Martin Fleisher
    Lisa M. DeAngelis
    Eric C. Holland
    Adília Hormigo
    Journal of Neuro-Oncology, 2011, 105 : 607 - 612
  • [48] To study involvement of serum matrix metalloproteinase-9 in pathogenesis of myocardial infarction
    Tserendavaa, Sumiya
    Enkhtaivan, Odkhuu
    Shagdar, Zorigoo
    Malchinkhuu, Munkhzol
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C158 - C159
  • [49] Effect of advanced glycation end products, extracellular matrix metalloproteinase inducer and matrix metalloproteinases on type-I collagen metabolism
    Li, Wang
    Ling, Wang
    Teng, Xiaomei
    Quan, Cuixia
    Cai, Shengnan
    Hu, Shuqun
    BIOMEDICAL REPORTS, 2016, 4 (06) : 691 - 693
  • [50] Increased serum matrix metalloproteinase-9 levels in neuropsychiatric SLE.
    Hietaharju, AJ
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S197 - S197
12345